Congratulations to Professor Alun Davies on his recent funding success.
Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*
January 2024
| Proposal Dept/Group | PI name | Funder | Project title | Amount (£)** |
| Anaesthetics | David Antcliffe | NIHR National Institute for Health Research | NIHR DSE Award – Medical Data Science | £152,054.00 |
| Cancer | Jonathan Krell | Imperial College Healthcare NHS Trust | A Phase IB open label, dose-escalation study to assess the safety, pharmacokinetics and clinical activity of NUC-1031 given on days 1 & 8 with carboplatin on day 1, q3-weekly for 6 cycles in participants with recurrent ovarian cancer | £92,391.00 |
| Cancer | Iain McNeish | NIHR National Institute for Health Research | Re: Imperial Experimental Cancer Medicine Centre (ECMC) | £1,185,460.01 |
| Cancer | Charlotte Bevan | Prostate Cancer UK | Understanding the abscopal effect in prostate cancer | £1,583,074.89 |
| Cancer | David Pinato | Imperial College Healthcare NHS Trust | Clinical Research Fellow to support early phase trials in oncology | £324,825.05 |
| Vascular | Alun Davies | NIHR National Institute for Health Research | Inpatient GRAduated Compression stocking use as an adjunct to Extended duration pharmacoprophylaxis for venous thromboembolism prevention – the GRACE multi-centre randomised controlled trial | £2,697,916.73 |
Congratulations to Professor Janet Powell on her recent funding success.
February 2024
| Proposal Dept/Group | PI name | Funder | Project title | Amount (£)** |
| Anaesthetics | Michael Wilson | British Journal of Anaesthesia | Mechanisms of early macrophage activation and sensitisation during VILI | £116,514.00 |
| Cancer | Matthew Williams | MacMillan Cancer Support | Indigo Community INvestigating DIGital Outcomes in the Community | £100,000.00 |
| Cancer | Matthew Williams | Breast Cancer Now | Improving outcomes for breast cancer patients with brain metastases: a pilot nonrandomised single arm Phase 2 clinical trial in patients with primary breast cancer and brain metastases who are not suitable for stereotactic radiotherapy, embedded in a national needs analysis | £173,412.41 |
| Centre for Health Policy | David Nabarro | The Huo Family Foundation UK Limited | Supporting Children and Young People to Cope and Act in the Climate Crisis | £153,845.99 |
| General Surgery | Ara Darzi | The Health Foundation | Network Data Lab Phase-2 | £150,835.00 |
| HPB | Nagy Habib | EU Underwrite – Innovate UK | APPEAL (Antivirus Pandemic Preparedness European Platform) | £475,084.01 |
| OG | Christopher Peters | NIHR National Institute for Health Research | The PICCOS Trial (PIPAC in Cancers of the Colon, Ovaries and Stomach): A randomised controlled phase II trial in Colorectal, Ovarian and Stomach cancers to define the efficacy of Pressurised IntraPeritoneal Aerosolised Chemotherapy (PIPAC) in the management of peritoneal metastases. | £124,981.07 |
| Simulation Centre | Fernando Bello | The Royal Marsden Cancer Charity | Digital Rectal Examination Training System – DiRECT | £21,000.00 |
| Vascular | Alun Davies | NIHR National Institute for Health Research | A randomised controlled trial assessing the clinical and cost-effectiveness of Endovascular vs. Open revascularisation in severe oCClusive aorto-iliac disease. The EVOCC Trial. | £54,252.65 |
| Vascular | Janet Powell | BHF British Heart Foundation | WARRIOR’s | £2,257,539.15 |
Congratulations to Dr Anke Nijhuis on her recent funding success.
March 2024
| Proposal Dept/Group | PI name | Funder | Project title | Amount (£)** |
| Vascular | Alun Davies | Actegy Limited | Actegy -monitoring costs | 57,870 |
| Cancer | Iain McNeish | CRUK Cancer Research UK | Kelly Gleason CRUK Salary Support – Clinical Research Committee – Research Nurses Quinquennial Review – November 2023 | 88,555 |
| Vascular | Alun Davies | Imperial College Healthcare NHS Trust | CRF post | 247,025 |
| Oesophageal-gastric | Sameera Sharma | NIHR National Institute for Health Research | Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasm | 561,856 |
| Cancer | James Flanagan | CRUK Cancer Research UK | The Cancer Loyalty Card Study (CLOCS) | 563,723 |
| Cancer | Anke Nijhuis | CRUK Cancer Research UK | Targeting RNA splicing as a novel therapeutic strategy in ovarian cancer | 1,138,235 |
** This is the total project value, including subprojects.
*Dude, where’s my grant? A disclaimer:
To ensure the quality and accuracy of the information published on this blog, we source our data directly from the College’s strategic reporting dashboards, relating to FoM. This means that, typically, we only include awards on this list which have been set up on the College’s grants management system, in accordance with the Joint Research Office’s policies and processes. As a result, there may be a delay in promoting some awards.